Expert Interview
Discussing the standard of care of patients with NSCLC, with a focus on PD-1/PD-L1 inhibitors and the potential of GSK's dostarlimab in this space.
Ticker(s): GSKInstitution: Weiss Hospital
- Director, Medical Oncology at Weiss Memorial Hospital
- Oncologist whose area of expertise includes breast cancer, lung cancer, lymphoma, genitourinary cancer, and GI cancer
- Currently manages 20 patients with NSCLC
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
